back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-12-02 18:28 Tx date 2025-11-26 |
$ZYUS
ZYUS Life Sciences Corporation |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+93,558 vol |
||
| Filed 2025-12-02 18:26 Tx date 2025-11-26 |
$ZYUS
ZYUS Life Sciences Corporation |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
$60,812
+93,558 vol $0.65 each |
93,558 | |
| Filed 2025-12-02 18:13 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-12-01 15:08 Tx date 2025-11-26 |
$ZYUS
ZYUS Life Sciences Corporation |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+93,558 vol |
||
| Filed 2025-12-01 15:08 Tx date 2025-11-26 |
$ZYUS
ZYUS Life Sciences Corporation |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+93,558 vol |
402,560 | |
| Filed 2024-08-28 17:33 Tx date 2024-08-26 |
$ZYUS
ZYUS Life Sciences Corporation |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$205,262
+157,894 vol $1.30 each |
157,894 | |
| Filed 2024-08-28 17:28 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-08-28 17:27 Tx date 2024-08-26 |
$ZYUS
ZYUS Life Sciences Corporation |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$149,999
+157,894 vol $0.95 each |
309,002 | |
| Filed 2023-06-19 13:08 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
12,618 | ||
| Filed 2023-06-19 13:06 Tx date 2023-06-09 |
$ZYUS
ZYUS Life Sciences Corporation |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
151,108 | ||
| Filed 2018-02-28 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-28 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-28 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,180 | ||
| Filed 2018-02-20 Tx date 2018-02-16 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,967
+5,332 vol $4.68 each |
10,840 | |
| Filed 2018-02-20 Tx date 2018-02-16 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,114
+7,200 vol $1.68 each |
18,040 | |
| Filed 2018-02-20 Tx date 2018-02-16 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,971.09
-5,332 vol $1.68 each |
7,200 | |
| Filed 2018-02-20 Tx date 2018-02-16 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,114
-7,200 vol $1.68 each |
0 | |
| Filed 2017-12-11 Tx date 2016-11-01 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-11 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
-$30,300 vol |
$0 | |
| Filed 2017-12-11 Tx date 2017-01-25 |
$CMED
CanniMed Therapeutics Inc. |
Hoyt, Richard
4 - Director of Issuer
Direct Ownership
|
Convertible Debentures
36 - Conversion or exchange
|
$
+$5,508 vol $4.60 each |